ProCE Banner Activity

Redefining the Possibilities for Patients With HER2-Positive Gastroesophageal Cancers

Slideset

Download these slides adapted from a dynamic CCO roundtable webinar for expert insights into testing for and treating HER2-positive gastroesophageal cancers.

Released: June 03, 2024

Expiration: June 02, 2025

Share

Faculty

Jaffer Ajani

Jaffer Ajani, MD

Professor 
Division of Cancer Medicine
Department of Gastrointestinal Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

Nataliya Uboha

Nataliya Uboha, MD, PhD

Faculty Leader for Early Phase Oncology Therapeutics Program
Associate Professor, Department of Medicine
Section of Hematology & Oncology
University of Wisconsin
Madison, Wisconsin

Zev A. Wainberg

Zev A. Wainberg, MD

Professor of Medicine and Surgery
Co-Director, GI Oncology
Director, Early Phase Clinical Research Program
Jonsson Comprehensive Cancer Center
UCLA School of Medicine
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca